HCP Live
Contagion LiveCGT LiveNeurology LiveHCP LiveOncology LiveContemporary PediatricsContemporary OBGYNEndocrinology NetworkPractical CardiologyRheumatology Netowrk
  • MJHLS Brand Logo

© 2022 MJH Life Sciences™ , NeurologyLive – Clinical Neurology News and Neurology Expert Insights. All rights reserved.

Neuromuscular

The NeurologyLive neuromuscular disease clinical focus page offers updates and information related to the clinical care and management of individuals with neuromuscular diseases such as amyotrophic lateral sclerosis, Duchenne muscular dystrophy, cerebral palsy, and spinal muscular atrophy, as well as rare diseases. This page consists of news, podcasts, and videos about the latest FDA actions, clinical guideline updates, interviews with physicians, study and clinical trial findings, and more.

NeurologyLive® Brain Games: August 14, 2022

August 14, 2022

Article

Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is multiple sclerosis.

Stigma Adds to Depressive Symptoms in Epilepsy, Parkinson Disease and Diabetes Show Increased Neuroaxonal Damage, ICER Publishes Report on ALS Treatments

August 13, 2022

Video

Neurology News Network for the week of August 13, 2022. [WATCH TIME: 4 minutes]

NeurologyLive® Friday 5 — August 12, 2022

August 12, 2022

Article

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending August 12, 2022.

Two Patient Deaths Reported With Zolgensma Administration in SMA

August 12, 2022

Article

The deaths, occurring shortly after treatment infusion, were because of acute liver injury, which is a known risk associated with the Novartis gene therapy.

Episode 70: Raising Awareness of Acute Flaccid Myelitis

August 12, 2022

Podcast

Mind Moments®, a podcast from NeurologyLive®, brings you an exclusive interview with Olwen C. Murphy, MBBCh; and Matthew R. Vogt, MD, PhD.

This Week on NeurologyLive® — August 8, 2022

August 08, 2022

Article

Here's some of what is coming soon to NeurologyLive® this week.

ICER Releases Report Comparing Cost-Effectiveness of ALS Agents Oral Edaravone and AMX0035

August 07, 2022

Article

After recently receiving approval in Canada, AMX0035 looks to join the US market alongside riluzole and edaravone, the only FDA-approved therapeutics that slow disease progression in ALS.

NeurologyLive® Brain Games: August 7, 2022

August 07, 2022

Article

Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is neuromyelitis optica spectrum disorder.

NeurologyLive® Friday 5 — August 5, 2022

August 05, 2022

Article

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending August 5, 2022.

Alnylam Reports Positive Data on Patisiran in APOLLO-B Trial of ATTR Amyloidosis With Cardiomyopathy

August 04, 2022

Article

The Alnylam Pharmaceuticals agent, already approved for the treatment of polyneuropathy in those with hATTR amyloidosis, has now shown promise as a therapeutic option for patients with ATTR amyloidosis with cardiomyopathy.